Patent · US Active

Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes

US8415352B2 · kind B2 · utility

1Cited by

2References

11Claims

0Family size

Assignee

MERCK PATENT GESELLSCHAFT MIT BESHRANK TER HAFTUNG · DE

Inventors

Gerard Botton · Buc, FR
Eric Valeur · Brétigny-sur-Orge, FR
Micheline Kergoat · Les Ulis, FR
Christine Charon · Gometz-le-Châtel, FR
Samer Elbawab · Les Ulis, FR

Key dates

Filing date	Jan 15, 2009
Grant date	Apr 9, 2013
Priority date	—
Expiry date	Jan 15, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D405/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to quinoxalinone derivatives of formula (I):wherein R1, R2, R3, R4, R5 and R6 are as defined herein, as insulin secretion stimulators. Specific such quinoxaline compounds are also an aspect of the invention. The invention also relates to the preparation and use of these quinoxalinone derivatives for the prophylaxis and/or treatment of diabetes and pathologies associated.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.